Skip to main content
SpringerLink
Log in

Effects of landiolol on refractory tachyarrhythmia after total cavopulmonary connection: a retrospective, observational, cohort study

  • Clinical Report
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

The onset of tachyarrhythmia after the Fontan procedure (total cavopulmonary connection; TCPC) should be considered a medical emergency. Landiolol is an ultra-short-acting β1-selective blocker whose effect on tachyarrhythmia after TCPC is unclear. We evaluated the efficacy and safety of landiolol for tachyarrhythmia after TCPC. Consecutive patients undergoing TCPC were enrolled from January 2007 to December 2011. Of 435 pediatric open heart surgeries, 28 patients underwent TCPC. Of the 28 patients, 13 were treated with landiolol for critical tachyarrhythmia. Excluding three patients who received landiolol during surgery, we investigated the remaining 10 patients and statistical analysis was performed without a 10-year-old patient as outlier. The median age was 4.08 years. The subjects comprised five patients with sinus tachycardia, four with junctional ectopic tachycardia and one with paroxysmal supraventricular tachycardia. The initial dose was 4.7 ± 2.3 μg/kg/min, without a loading dose. Landiolol reduced the heart rate from 151.8 ± 23.2 at the start to 132.9 ± 20.0 at 1 h and 126.1 ± 24.9 at 2 h (P < 0.01 and P < 0.01, respectively), without blood pressure decrease (P = 0.235). Landiolol was effective in treating critical tachyarrhythmia without hemodynamic deterioration. We believe that landiolol is a promising option for postoperative tachyarrhythmia after the Fontan procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ono M, Boethig D, Goerler H, Lange M, Westhoff-Bleck M, Breymann T. Clinical outcome of patients 20 years after Fontan operation–effect of fenestration on late morbidity. Eur J Cardiothorac Surg. 2006;30:923–9.

    Article  PubMed  Google Scholar 

  2. Sakurai T, Kado H, Nakano T, Hinokiyama K, Oda S, Sugiura J, Ushijima T, Ueda Y. The impact of extracardiac conduit-total cavopulmonary connection on apicocaval juxtaposition. Eur J Cardiothorac Surg. 2010;38:439–44.

    Article  PubMed  Google Scholar 

  3. Balaji S, Daga A, Bradley DJ, Etheridge SP, Law IH, Batra AS, Sanatani S, Singh AK, Gajewski KK, Tsao S, Singh HR, Tisma-Dupanovic S, Tateno S, Takamuro M, Nakajima H, Roos-Hesselink JW, Shah M. An international multicenter study comparing arrhythmia prevalence between the intracardiac lateral tunnel and the extracardiac conduit type of Fontan operations. J Thorac Cardiovasc Surg. 2014;148:576–81.

    Article  PubMed  Google Scholar 

  4. Balaji S, Gewillig M, Bull C, de Leval MR, Deanfield JE. Arrhythmias after the Fontan procedure. Comparison of total cavopulmonary connection and atriopulmonary connection. Circulation. 1991;84: III162–7.

  5. Stephenson EA, Lu M, Berul CI, Etheridge SP, Idriss SF, Margossian R, Reed JH, Prakash A, Sleeper LA, Vetter VL, Blaufox AD. Pediatric Heart Network Investigators. Arrhythmias in a contemporary fontan cohort: prevalence and clinical associations in a multicenter cross-sectional study. J Am Coll Cardiol. 2010;56:890–6.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Giannakoulas G, Dimopoulos K, Yuksel S, Inuzuka R, Pijuan-Domenech A, Hussain W, Tay EL, Gatzoulis MA, Wong T. Atrial tachyarrhythmias late after Fontan operation are related to increase in mortality and hospitalization. Int J Cardiol. 2012;157:221–6.

    Article  PubMed  Google Scholar 

  7. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E. Task force on the management of grown-up congenital heart disease of the European Society of Cardiology, Association for European Paediatric Cardiology, ESC Committee for Practice Guidelines. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31:2915–57.

    Article  PubMed  Google Scholar 

  8. Abrams D, Schilling R. Mechanism and mapping of atrial arrhythmia in the modified Fontan circulation. Heart Rhythm. 2005;2:1138–44.

    Article  PubMed  Google Scholar 

  9. Atarashi H, Kuruma A, Yashima M, Saitoh H, Ino T, Endoh Y, Hayakawa H. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther. 2000;68:143–50.

    Article  CAS  PubMed  Google Scholar 

  10. Sezai A, Minami K, Nakai T, Hata M, Yoshitake I, Wakui S, Shiono M, Hirayama A. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. J Thorac Cardiovasc Surg. 2011;141:1478–87.

    Article  CAS  PubMed  Google Scholar 

  11. Sakamoto A, Kitakaze M, Takamoto S, Namiki A, Kasanuki H, Hosoda S, Group J-KS. Landiolol, an ultra-short-acting β 1-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study). Circ J. 2012;76:1097–101.

    Article  CAS  PubMed  Google Scholar 

  12. Tokunaga C, Hiramatsu Y, Kanemoto S, Takahashi-Igari M, Abe M, Horigome H, Sakakibara Y. Effects of landiolol hydrochloride on intractable tachyarrhythmia after pediatric cardiac surgery. Ann Thorac Surg. 2013;95:1685–8.

    Article  PubMed  Google Scholar 

  13. Hasegawa T, Oshima Y, Maruo A, Matsuhisa H, Kadowaki T, Noda R. Landiolol for junctional ectopic tachycardia refractory to amiodarone after pediatric cardiac surgery. Gen Thorac Cardiovasc Surg. 2013;61:350–2.

    Article  PubMed  Google Scholar 

  14. Wong KK, Potts JE, Etheridge SP, Sanatani S. Medications used to manage supraventricular tachycardia in the infant a North American survey. Pediatr Cardiol. 2006;27:199–203.

    Article  CAS  PubMed  Google Scholar 

  15. Etheridge SP, Craig JE, Compton SJ. Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants. Am Heart J. 2001;141:105–10.

    Article  CAS  PubMed  Google Scholar 

  16. Burri S, Hug MI, Bauersfeld U. Efficacy and safety of intravenous amiodarone for incessant tachycardias in infants. Eur J Pediatr. 2003;162:880–4.

    Article  CAS  PubMed  Google Scholar 

  17. Saul JP, Scott WA, Brown S, Marantz P, Acevedo V, Etheridge SP, Perry JC, Triedman JK, Burriss SW, Cargo P, Graepel J, Koskelo EK, Wang R, Investigators IAP. Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. Circulation. 2005;112:3470–7.

    Article  CAS  PubMed  Google Scholar 

  18. Wiest DB, Garner SS, Uber WE, Sade RM. Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg. 1998;115:890–7.

    Article  CAS  PubMed  Google Scholar 

  19. Tabbutt S, Nicolson SC, Adamson PC, Zhang X, Hoffman ML, Wells W, Backer CL, McGowan FX, Tweddell JS, Bokesch P, Schreiner M. The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial. J Thorac Cardiovasc Surg. 2008;136:321–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology and Medical Crisis Management, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

    Kentaro Miyake, Saya Yoshizawa, Maiko Tomita, Mitsunori Miyazu, Yoshiki Sento, Shinichiro Yoshimura & Kazuya Sobue

  2. Department of Anesthesiology, Aichi Medical University School of Medicine, 1-1 Karimata Yazako Nagakute, Aichi, 480-1195, Japan

    Yoshihito Fujita

Authors
  1. Kentaro Miyake
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshihito Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Saya Yoshizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maiko Tomita
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mitsunori Miyazu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshiki Sento
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shinichiro Yoshimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kazuya Sobue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshihito Fujita.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miyake, K., Fujita, Y., Yoshizawa, S. et al. Effects of landiolol on refractory tachyarrhythmia after total cavopulmonary connection: a retrospective, observational, cohort study. J Anesth 30, 331–336 (2016). https://doi.org/10.1007/s00540-015-2119-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-015-2119-4

Keywords

Search

Navigation